A study of nintedanib in patients with ILD associated with systemic sclerosis showed the treatment had only limited improvement. Although these patients had a lower rate of decline in forced vital capacity than those on placebo, nintedanib did not result in clinical benefits for other manifestations of systemic sclerosis…
MIAMI (Reuters)—Democratic presidential contenders battled over healthcare coverage and border policy on Wednesday during a surprisingly heated first debate that laid bare the party’s divisions on whether to abolish private insurance and shift to a Medicare-for-All system. In the first round of back-to-back debates, several of the lesser-known candidates vied for attention in the crowded…
Adding certolizumab pegol to background medication is better than adding a placebo for patients with active nonradiographic axial spondyloarthritis, according to a new study…
The clinical sessions at the 2019 ACR/ARP Annual Meeting feature cutting-edge techniques in rheumatology and enable attendees to hone new skills and explore medically relevant topics…
This year, the Annual Meeting Planning Committee has designed an engaging program, bringing together the best experts to address important topics. Here’s a sneak peek at what’s new…
Machine learning, immunology, the metabolism—are just a few of the topics addressed during…
Rheumatologists, behavioral specialists, pharmacists and other healthcare professionals are working in the Autoimmunity Institute at Allegheny Health Network, Pittsburgh, to care for the whole patient…
In a recent study, tanezumab proved safe and effective in the treatment of knee and hip osteoarthritis…
The phase 3, RA-BEAM study found RA patients who were switched from adalimumab to baricitinib experienced improvements in disease control even in the absence of an adalimumab washout. In the study, the change was not associated with an increase in adverse events or infections…
NEW YORK (Reuters Health)—The overall 30-day costs of caring for Medicare patients are lower at teaching hospitals, according to data from the Medicare inpatient file. “We found it really interesting that the lower costs seen at major teaching hospitals was driven primarily by lower costs after discharge from the hospital,” Dr. Laura G. Burke from…